Gada Italia’s Neuroscience Business Unit was created with the aim of supporting hospitals and healthcare professionals in managing neurological disorders through the introduction of advanced, non-invasive therapeutic solutions focused on patient wellbeing.
We work alongside clinical centers to make innovative technologies accessible, opening new perspectives in the treatment of complex neurological disorders.
Our commitment is to support physicians in their daily practice by providing not only state-of-the-art technological tools, but also training, consultancy, and continuous service designed to ensure the effectiveness, safety, and sustainability of the therapeutic pathway.
We strongly believe in an integrated model, in which the adoption of new technologies is accompanied by active and competent support: from the clinical evaluation phase to implementation in the operating room, and through to post-treatment monitoring. In this context, our Business Unit positions itself as a strategic partner for healthcare facilities wishing to expand their therapeutic offering in the neurological field, enhancing a multidisciplinary approach and always placing the patient at the center.
With a forward-looking vision, we continue to invest in the implementation of solutions that improve access to care, reduce intervention invasiveness, and contribute to the evolution of neurological medicine toward increasingly higher standards of quality and humanization.
La Business Unit Neuroscienze di Gada Italia si dedica all’introduzione di soluzioni tecnologiche all’avanguardia per il trattamento minimamente invasivo dei disturbi neurologici: le tecnologie offerte in questo ambito, utilizzando ultrasuoni focalizzati guidati da risonanza magnetica (MRgFUS), sono in grado di trattare patologie neurologiche selezionate senza necessità di incisioni chirurgiche.
I disturbi neurologici, come il tremore essenziale e la Malattia di Parkinson, possono avere un impatto significativo sulla qualità della vita dei pazienti. Tradizionalmente, le opzioni terapeutiche includevano farmaci o interventi chirurgici invasivi. Tuttavia, non tutti i pazienti rispondono adeguatamente ai farmaci, e le procedure chirurgiche comportano rischi e tempi di recupero prolungati.
In questo scenario, la soluzione offerta da Gada Italia è l’Exablate 4000 di Insightec, un’alternativa terapeutica innovativa e meno invasiva.
L’Exablate 4000 è progettato per eseguire ablazioni precise di tessuti cerebrali attraverso l’uso combinato di ultrasuoni focalizzati e imaging a risonanza magnetica. Questa tecnologia consente ai medici di visualizzare in tempo reale l’area da trattare e di monitorare la temperatura del tessuto, garantendo un intervento sicuro ed efficace. Il trattamento è generalmente eseguito in un’unica sessione e non richiede incisioni, riducendo significativamente i rischi associati alle procedure chirurgiche tradizionali.
L’Exablate 4000 di Insightec rappresenta una soluzione tecnologica avanzata che risponde alle esigenze cliniche attuali, offrendo ai pazienti opzioni terapeutiche più sicure ed efficaci per la gestione dei disturbi neurologici.
Gada Italia’s Neuroscience Business Unit is dedicated to introducing cutting-edge technological solutions for the non-invasive treatment of neurological disorders. The technologies offered in this field, based on MR-guided focused ultrasound (MRgFUS), are able to treat selected neurological conditions without the need for surgical incisions.
Neurological disorders, such as essential tremor and tremor-dominant Parkinson’s disease, can have a significant impact on patients’ quality of life. Traditionally, therapeutic options included medications or invasive surgical procedures. However, not all patients respond adequately to pharmacological therapy, and surgical procedures carry risks and prolonged recovery times.
In this scenario, the solution offered by Gada Italia is the Exablate 4000 by Insightec —an innovative and less invasive therapeutic alternative.
The Exablate 4000 is designed to perform precise ablations of brain tissue through the combined use of focused ultrasound and magnetic resonance imaging. This technology allows physicians to visualize the treatment area in real time and monitor tissue temperature, ensuring a safe and effective intervention. Treatment is typically performed in a single session and does not require incisions, significantly reducing the risks associated with traditional surgical procedures.
The Exablate 4000 by Insightec represents an advanced technological solution that meets current clinical needs, offering patients safer and more effective therapeutic options for the management of neurological disorders.